share_log

PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

PVH Posts Q4 Results, Joins Humana, CVS Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

PVH公佈第四季度業績,加入Humana、CVS Health和其他大股的行列,在週二的盤前交易中走低
Benzinga ·  04/02 18:26

U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday.

今天上午美國股票期貨走低,道瓊斯指數期貨週二下跌超過100點。

Shares of PVH Corp. (NYSE:PVH) fell sharply in today's pre-market trading after the company reported fourth-quarter financial results and issued guidance.

PVH Corp.(紐約證券交易所代碼:PVH)的股價在今天的盤前交易中大幅下跌,此前該公司公佈了第四季度財務業績併發布了指導方針。

PVH reported quarterly earnings of $3.72 per share which beat the analyst consensus estimate of $3.53 by 5.38% and is a 56.3% increase over earnings of $2.38 per share from the same period last year. Quarterly sales came in at $2.49 billion which beat the analyst consensus estimate of $2.42 billion by 2.89%, according to data from Benzinga Pro.

PVH公佈的季度每股收益爲3.72美元,比分析師普遍預期的3.53美元高出5.38%,比去年同期的每股收益2.38美元增長了56.3%。根據Benzinga Pro的數據,季度銷售額爲24.9億美元,比分析師共識估計的24.2億美元高出2.89%。

The company sees fiscal year 2024 earnings of between $10.75 and $11.00 per share, versus the $10.48 estimate. Revenue is projected to decrease between 6% and 7% compared to 2023.

該公司預計,2024財年的每股收益在10.75美元至11.00美元之間,而預期爲10.48美元。與2023年相比,收入預計將下降6%至7%。

PVH shares tumbled 23.4% to $107.00 in pre-market trading.

在盤前交易中,PVH股價下跌23.4%,至107.00美元。

Here are some big stocks recording losses in today's pre-market trading session.

以下是一些在今天的盤前交易時段中錄得虧損的大型股票。

  • Fractyl Health, Inc. (NASDAQ:GUTS) shares dipped 13.7% to $6.43 in pre-market trading amid volatility after the company reported fourth-quarter financial results.
  • GCT Semiconductor Holding, Inc. (NASDAQ:GCTS) shares declined 12.6% to $15.82 in pre-market trading after declining over 45% on Monday. GCT Semiconductor appointed Nelson C. Chan to Board of Directors.
  • Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) shares fell 11.1% to $1.85 in pre-market trading after declining around 9% on Monday.
  • Humana Inc. (NYSE:HUM) shares fell 8.8% to $320.55 in pre-market trading after the Centers for Medicare & Medicaid Services (CMS) finalized payment updates. The CMS announced Monday that it finalized the calendar year 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) programs that updates payment policies for these programs and ensures payment accuracy.
  • MicroStrategy Incorporated (NASDAQ:MSTR) shares declined 7.1% to $1,521.00 in pre-market trading amid a decline in Bitcoin.
  • Bit Digital, Inc. (NASDAQ:BTBT) shares fell 5.4% to $2.61 in pre-market trading amid a decline in Bitcoin.
  • CVS Health Corporation (NYSE:CVS) shares declined 5.2% to $75.41 in pre-market trading after the Centers for Medicare & Medicaid Services (CMS) finalized payment updates.
  • Lotus Technology Inc. (NASDAQ:LOT) shares declined 4.7% to $6.54 in pre-market trading. Lotus Technology is expected to report its unaudited fourth quarter before the opening bell on April 8, 2024.
  • Fractyl Health, Inc.(納斯達克股票代碼:GUTS)公佈第四季度財務業績後,由於波動,該公司股價在盤前交易中下跌13.7%,至6.43美元。
  • GCT半導體控股公司(納斯達克股票代碼:GCTS)股價在週一下跌超過45%後,在盤前交易中下跌12.6%,至15.82美元。GCT 半導體任命陳小龍爲董事會成員。
  • Petco健康與保健公司(納斯達克股票代碼:WOOF)股價在週一下跌約9%後,在盤前交易中下跌了11.1%,至1.85美元。
  • 在醫療保險和醫療補助服務中心(CMS)完成付款更新後,Humana Inc.(紐約證券交易所代碼:HUM)股價在盤前交易中下跌8.8%,至320.55美元。CMS週一宣佈,它完成了Medicare Advantage(MA)和Medicare D部分處方藥(D部分)計劃的2025年日曆年費率公告,該公告更新了這些計劃的支付政策並確保了付款的準確性。
  • 由於比特幣下跌,微策略公司(納斯達克股票代碼:MSTR)股價在盤前交易中下跌7.1%,至1,521.00美元。
  • 由於比特幣下跌,比特數字公司(納斯達克股票代碼:BTBT)股價在盤前交易中下跌5.4%,至2.61美元。
  • 在醫療保險和醫療補助服務中心(CMS)完成付款更新後,CVS Health Corporation(紐約證券交易所代碼:CVS)股價在盤前交易中下跌5.2%,至75.41美元。
  • 蓮花科技公司(納斯達克股票代碼:LOT)股價在盤前交易中下跌4.7%,至6.54美元。預計蓮花科技將在2024年4月8日開盤前公佈其未經審計的第四季度。

Now Read This: Investor Sentiment Improves, But Dow Falls Over 200 Points

現在讀這個: 投資者情緒改善,但道瓊斯指數下跌超過200點

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論